Really excited for the year ahead ASCI and grateful for the opportunity! beta.the-asci.org/news/asci-news…

Finally, our second tweet of 2023 holds super exciting NEWS:) Our story on a non-canonical role of class 3 PIK as a transcriptional co-activator of the circadian clock is out in Nature Cell Biology! One more secret of class 3 PI3K revealed and many more to discover.

#Alpelisib is well tolerated and clinically effective treatment for many patients with #PROS #PIK3CA #raredisease @Canaudlab Alan Irvine bit.ly/3PkeFF1

📄New in Cell Reports by Gallazzini group: Lipocalin-2 induces mitochondrial dysfunction in renal tubular cells via mTOR pathway activation. Congrats to fabiola.terzi's lab INEM NECKER Inserm @INSB_CNRS Université Paris Cité for this innovative work 👏 cell.com/cell-reports/f…

Full house today at INEM as we welcome Inserm CEO Pr Didier Samuel. Looking forward to a day of insightful discussions and knowledge exchange. #Science #partnership #innovation

nature.com/articles/s4146… Many thanks to Aurore and Nicolas for this beautiful collaborative work highlighting the major role of YAP/TAZ in the kidney linking autophagy and mechanical stress !

Feb 2 at 12:00 I will be giving a #fridayseminar INEM NECKER on mitochondrial mechanotransduction hosted by fabiola.terzi. Can’t wait for nice discussions and seeing friends.

📸 Aujourd’hui, nous avons eu l’immense plaisir d’accueillir Line Renaud et Thierry Lhermitte parrain de la Fondation pour la Recherche Médicale, pour parler science, maladies rares et avenir de la recherche médicale avec Guillaume Canaud (MD, PhD). Un grand jour pour l'innovation et l'espoir ! 🧬✨

En cette #JournéeInternationaleDesDroitsDesFemmes, découvrez les histoires de fabiola.terzi, Yasmine Belkaid, Bana Jabri et Florence Niedergang, déterminées à promouvoir diversité et égalité dans la science. 🔬👩🏼‍🔬Institut Cochin Institut Imagine Institut Pasteur, since 1887 la-croix.com/femmes-de-scie…

🗞️Jean-Claude Weill en vedette dans Le Monde. Découvrez l'immunologiste derrière 📖 « Éloge de l'Imprévu », une ode à l'inattendu en science et dans la vie. Un parcours qui inspire et éclaire. 🌟Inserm Université Paris Cité CNRS 🌍 Assistance Publique – Hôpitaux de Paris (AP-HP) lemonde.fr/sciences/artic…

Heureux d'avoir accueilli Mme la Ministre Sylvie Retailleau et M. le Ministre YIN Hejun à l'INEM dans le cadre de la 15e édition du comité mixte franco-chinois. 🌍🔬 Un moment clé pour souligner notre engagement commun en faveur de la santé. Inserm Université Paris Cité CNRS 🌍 Assistance Publique – Hôpitaux de Paris (AP-HP)

#France2030 🔬🏅Ce matin, à Institut Pasteur, since 1887, les ministres Sylvie Retailleau, Frédéric Valletoux avec Lise Alter, directrice de l’Agence de l'innovation en santé ont dévoilé le nom des 22 lauréats du dispositif « Chaires d’excellence en #Biologie / #Santé » de France 2030⤵️

Very happy to see our own Matthieu Mahévas among the celebrated laureates! A well-deserved acknowledgment for his contributions to Biomedical Research. 🎉 #France2030 🔗The recipients and selected projects: enseignementsup-recherche.gouv.fr/sites/default/…

🌟NEW study by Yamaguchi et al. in Journal of Clinical Investigation reveals the pivotal role of PIK3CA in proliferative glomerulonephritis and lupus nephritis. Alpelisib shows promise in improving kidney function and reducing inflammation. Guillaume Canaud (MD, PhD) 🔗Read more: jci.org/articles/view/…

Researcher @WUNephrology by day, Rock n Roller by night, read about Isnard Pierre and his band Benny and the Frogs in #STL! Keep on Rockin'! nephrology.wustl.edu/researcher-pie…

Thrilled to share our new review on ST applied to kidney diseases. Many thanks to Ben Humphreys for his great support and talent !!ajp.amjpathol.org/article/S0002-…

🚨 Postdoc opportunity in kidney disease research! The fabiola.terzi Lab is hiring a postdoctoral fellow to study CKD progression using mouse models, CRISPRi/a & molecular biosensors. Based in Paris, the position starts in April 2025. 📩Apply: institut-necker-enfants-malades.fr/index.php/offr…

[PUBLICATION] Podocyte-specific YAP activation drives crescentic glomerulonephritis via cross-talk with parietal epithelial cells. 🌙 A study from the Terzi & Pontoglio labs now out in Science Translational Medicine Science Magazine. science.org/doi/10.1126/sc…

Science Magazine Marco Pontoglio fabiola.terzi Isnard Pierre BioloGeek Guillaume Canaud (MD, PhD) Lisa Turinsky Nicolas Kuperwasser Marion Rabant SFR Necker The study highlights how YAP hyperactivation in podocytes reprograms cell fate and triggers PEC proliferation, revealing CTGF and HB-EGF as key mediators, and therapeutic targets, in crescentic glomerulonephritis.

Thrilled to share our work and truly honored to share senior autorship with fabiola.terzi ! Thanks Science Translational Medicine for publishing our work ! science.org/doi/10.1126/sc…